Advertisements



We are Sorry, This Page doesn't Exist


AbbVie"s Imbruvica Achieves Up to 7-Year Progression-Free Survival in Leukemia Patients

The research leader advises to begin treatment as quickly as possibleRelated Stocks: ABBV,.....»»

Category: blogSource: gurufocusDec 3rd, 2018

AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib

AbbVie (ABBV) submits regulatory applications in the United States and EU for upadacitinib, for the treatment of a.....»»

Category: personnelSource: nytDec 21st, 2018

Abbvie (ABBV) Dividend Stock Analysis for 2021

AbbVie Inc. (ABBV) discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company was created in 2013, when Abbott Laboratories split into two companies – Abbvie and Abbott. Abbvie.....»»

Category: blogSource: dividendgrowthinvestorMay 6th, 2021

"Halftime Report" Traders Weigh In On AbbVie, Chewy And More

On CNBC's "Fast Money Halftime Report," Jim Cramer advised a viewer to stay long in AbbVie Inc (NYSE: ABBV). He loves the stock and the yield. read more.....»»

Category: blogSource: benzingaMay 5th, 2021

AbbVie Stock Is Estimated To Be Fairly Valued

Related Stocks: ABBV,.....»»

Category: smallbizSource: nytApr 30th, 2021

Balasa Dinverno & Foltz Llc Buys Abbott Laboratories, AbbVie Inc, Tesla Inc, Sells Vanguard ...

Related Stocks: ABT, TSLA, ABBV, EBAY, ULTA, GILD, ALXN, MO, IVZ, BPOP, MNST,.....»»

Category: dealsSource: nytApr 29th, 2021

Addiction treatment center expanding in Dayton region, creating 25 new jobs

The organization currently operates local sites in Dayton, Middletown and Piqua, and it maintains four Greater Cincinnati facilities in Over-the-Rhine, Forest Park, Milford and Green Township......»»

Category: topSource: bizjournalsApr 25th, 2021

Brii, Vir Biotechnology VBI , start phase 2 trial of hepatitis B treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 21st, 2021

Citadel Investment Advisory, Inc. Buys AbbVie Inc, Microsoft Corp, FTI Consulting Inc

Related Stocks: ABBV, MSFT, FCN, KDP,.....»»

Category: worldSource: nytApr 20th, 2021

Tesla will soar 51% as huge first-quarter sales signal looming "green tidal wave," Wedbush says

Dan Ives said in a note that Congress might increase the electric-vehicle tax credit to $10,000 from $7,500 to "catalyze EV consumer demand." Tesla vehicles. Xinhua/Ding Ting via Getty Images Tesla.....»»

Category: smallbizSource: nytApr 5th, 2021

Tesla "green tidal wave" to send stock to $1,000

Tesla Inc. shares surged Monday after the electric-car maker reported first-quarter deliveries that signal a "green tidal wave" is headed for the industry, according to one Wall Street analyst......»»

Category: topSource: foxnewsApr 5th, 2021

Why AbbVie"s Stock is Trading Lower Today

The Price And Volume Action In AbbVie's Stock Today AbbVie (NYSE:ABBV) is currently down 5.54% to a price of $104.49. The stock's volume is currently 6.90 million, which is roughly 99.43% of its recent 30-day volume average of 6.94 million. read more.....»»

Category: blogSource: benzingaMar 17th, 2021

What are the green and orange dots on an iPhone? How to tell when apps are using your mic or camera

The green or orange dots on your iPhone signal when an app is using the camera or microphone, respectively. Yo.....»»

Category: worldSource: nytFeb 17th, 2021

AbbVie"s Allergan says FDA approves Botox for treatment of detrusor overactivity

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 10th, 2021

Unusual Options Activity Insight: AbbVie

AbbVie (NYSE:ABBV) shares experienced unusual options activity on Wednesday. The stock price moved up to $103.37 following the option alert. read more.....»»

Category: blogSource: benzingaFeb 3rd, 2021

AbbVie"s Potential Is "Underappreciated," Says Morgan Stanley Analyst

Despite the pandemic risk, one analyst at Morgan Stanley remains bullish on AbbVie Inc (NYSE: ABBV). The AbbVie Analyst David Risinger maintained an Overweight on AbbVie with a $95 price target.  Lates.....»»

Category: blogSource: benzingaMay 13th, 2020

Why AbbVie"s Stock Is Trading Higher Today

AbbVie (NYSE: ABBV) shares are trading higher on Monday. L.....»»

Category: blogSource: benzingaMay 11th, 2020

How does Gilead market a pandemic treatment?

In a matter of weeks, remdesivir has gone from a shelved, failed hepatitis C treatment to the center of a national effort to treat patients suffering from covid-19, the illness caused by the novel coronavirus......»»

Category: topSource: moneycentralMay 7th, 2020

How does Gilead market a pandemic treatment?

In a matter of weeks, remdesivir has gone from a shelved, failed hepatitis C treatment to the center of a national effort to treat patients suffering from covid-19, the illness caused by the novel coronavirus......»»

Category: topSource: moneycentralMay 7th, 2020

AbbVie Earnings: 5 Things for ABBV Stock Investors to Know About Q1

InvestorPlace - Stock Market News, Stock Advice & Trading Tips AbbVie (ABBV) earnings f.....»»

Category: topSource: investorplaceMay 2nd, 2020